Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers.
Bone morphogenetic proteins (BMPs) are currently approved for spinal fusion, tibial fracture repair, and maxillofacial bone regeneration. However, BMP pleiotropism, paradoxical activities on precursor cells, and unexpected side effects at local and ectopic sites may limit their usage. Thus, the need remains for alternative osteoinductive factors that provide more bone-specific activities with fewer adverse effects. Nell-1 [Nel-like molecule-1; Nel (a protein highly expressed in neural tissue encoding epidermal growth factor like domain)] is a novel osteogenic protein believed to specifically target cells committed to the osteogenic lineage. The objective of this project is to incorporate Nell-1 into a moldable putty carrier that can adapt to bony defects and deliver Nell-1 to the local microenvironment. We show here that moldability can be achieved by mixing hyaluronan hydrogel with two types of particles: demineralized bone powder for osteoconductivity, and biomimetic apatite-coated alginate/chitosan microparticles for controlled Nell-1 delivery. Besides enhancing overall osteoconductivity of the carrier, the biomimetic apatite coating also provides a more sustained release (approximately 15% cumulative release over 30 days) and greatly reduces the initial burst release that is observed with non-coated alginate/chitosan microparticles (approximately 40% release after 1 day). The efficacy of Nell-1 delivery from these carriers was evaluated in a rat spinal fusion model against Nell-free carriers as controls. At 4 weeks post-implantation, Nell-1 enhanced spinal fusion rates as assessed by manual palpation, radiographs, high-resolution micro-computerized tomography (microCT), and histology. This moldable putty carrier system appears to be a suitable carrier for promoting osteogenesis, and will be further evaluated in larger animal models over longer periods to follow the remodeling of the regenerated bone.
Lee
Min
M
Dental and Craniofacial Research Institute, University of California, Los Angeles, CA 90095, USA.
Li
Weiming
W
Siu
Ronald K
RK
Whang
Julie
J
Zhang
Xinli
X
Soo
Chia
C
Ting
Kang
K
Wu
Benjamin M
BM
D000464:Alginates / Q000737:chemistry*; D000818:Animals; D001031:Apatites / Q000737:chemistry*; D032701:Biomimetics; D019485:Bone Morphogenetic Proteins / Q000737:chemistry; D001861:Bone Regeneration; D048271:Chitosan / Q000737:chemistry*; D004337:Drug Carriers; D016503:Drug Delivery Systems; D006801:Humans; D006820:Hyaluronic Acid / Q000737:chemistry; D008297:Male; D008863:Microspheres; D023421:Models, Animal; D010012:Osteogenesis; D011506:Proteins / Q000737:chemistry*; D051381:Rats; D011923:Rats, Nude; D055114:X-Ray Microtomography / Q000379:methods
D000464:Alginates; D001031:Apatites; D019485:Bone Morphogenetic Proteins; D004337:Drug Carriers; D011506:Proteins; D006820:Hyaluronic Acid; D048271:Chitosan
Int J Pharm. 2002 Jan 31;232(1-2):225-34
11790506
Nat Mater. 2004 Aug;3(8):569-74
15258575
J Bone Joint Surg Am. 2003 May;85(5):905-11
12728043
Gene Ther. 2004 Sep;11(17):1312-20
15269709
Oncogene. 2002 Oct 17;21(47):7156-63
12370805
Biomaterials. 2002 May;23(9):1921-30
11996032
Biomaterials. 2004 Aug;25(17):3807-12
15020156
Otolaryngol Head Neck Surg. 2000 Nov;123(5):547-52
11077338
J Clin Invest. 2002 Sep;110(6):861-70
12235118
Endocr Rev. 2000 Aug;21(4):393-411
10950158
Biochem Biophys Res Commun. 1999 Nov 30;265(3):752-7
10600492
Hum Mol Genet. 2006 Apr 15;15(8):1329-41
16537572
Spine (Phila Pa 1976). 1989 Dec;14(12):1324-31
2617362
Plast Reconstr Surg. 1984 Jun;73(6):933-8
6374708
J Bone Miner Res. 2007 Jan;22(1):7-18
17042739
J Clin Periodontol. 2000 Sep;27(9):627-36
10983596
Trends Genet. 2003 Aug;19(8):458-66
12902164
J Cell Biol. 1994 Dec;127(6 Pt 1):1755-66
7798324
Biomaterials. 2004 Oct;25(22):5323-31
15110483
Biomaterials. 2005 Jun;26(18):3919-28
15626439
Spine J. 2007 Jan-Feb;7(1):50-60
17197333
Cleft Palate Craniofac J. 1993 Nov;30(6):579-81
8280737
Plast Reconstr Surg. 1996 Sep;98(3):567
8701000
Int J Pharm. 2000 May 15;201(1):51-8
10867264
J Pharm Sci. 1993 Sep;82(9):912-7
8229689
J Biomed Mater Res B Appl Biomater. 2005 Oct;75(1):81-90
16001421
Plast Reconstr Surg. 1995 Jan;95(1):5-13; discussion 14-20
7809267
J Bone Joint Surg Am. 2002 Dec;84(12):2123-34
12473698
Adv Drug Deliv Rev. 2007 May 30;59(4-5):234-48
17478007
Biomaterials. 2007 Feb;28(6):1267-79
17123600
DNA Cell Biol. 1993 Dec;12(10):871-80
8274220
Drug Dev Ind Pharm. 2001 May;27(5):393-400
11448046
Biomaterials. 2000 Dec;21(24):2589-98
11071608
Am J Pathol. 2006 Sep;169(3):903-15
16936265
Biochem Biophys Res Commun. 1999 Nov;265(1):79-86
10548494
Cell Biol Int. 2007 Aug;31(8):776-83
17324591
Plast Reconstr Surg. 1999 Jul;104(1):139-47
10597686
Kidney Int. 2000 Jun;57(6):2207-14
10844590
Biomaterials. 2005 Oct;26(30):5983-90
15894370
J Biomed Mater Res. 2001 Jan;54(1):76-86
11077405
Cell. 1997 May 30;89(5):755-64
9182763
J Bone Miner Res. 1999 Jan;14(1):80-9
9893069
Biomaterials. 2005 Jan;26(3):285-95
15262470
Genesis. 2003 Jan;35(1):43-56
12481298
Drug Dev Ind Pharm. 2002 Jul;28(6):621-30
12149954